Indofarma Tbk. vs Summarecon Agung Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Summarecon Agung Tbk. trades at Rp332 (market cap 5.48T, 21M 24h volume). The key difference: Summarecon Agung Tbk. is far larger — about 14× Indofarma Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | SMRA | |
|---|---|---|
Market Cap | 390.51B | 5.48T |
Volume | — | 21M |
Lot | — | 209.99K |
Turnover | — | 6.97B |
Average Price | — | 332.14 |
Value | — | 6.97B |
Indicative Equilibrium Price | — | 332 |
Indicative Equilibrium Volume | — | 19.86K |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Summarecon Agung Tbk (the Company) was established within the framework of the Domestic Capital Investment Law based on notarial deed No. 308 dated November 26, 1975 of Ridwan Suselo, S.H. PT. Summarecon Agung Tbk is one of the nation`s leading township developers. Entering its twenty-forth year, the original 10-hectare landbank it started with has turned into a vibrant, 500 hectare township in North Jakarta where commercial vivacity peacefully coexists with its houses numbering in the tens of thousands.
Read more on SMRA →